![]() |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|
|
![]() The company has a strong pipeline of products under development, including treatments for MS and neuroimmunology, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropathic pain, and immunology related diseases. Biogen has collaboration and license agreements with various companies, including Acorda Therapeutics, Eisai Co., Ltd., and Sage Therapeutics, among others. Biogen was founded in 1978 and is headquartered in Cambridge, Massachusetts. The company is committed to developing innovative therapies to improve the lives of patients suffering from neurological and neurodegenerative d
|
||||||||||||
|
||||||||||||
|
||||||||||||
|